COPD Flashcards
What does COPD stand for?
Chronic obstructive pulmonary disease
What is COPD?
Non-reversible, long term deterioration in air flow through the lungs caused by damage to lung tissue.
Emphysema + Chronic bronchitis
What causes COPD?
Smoking
Alpha 1 antitrypsin deficiency - early onset <4.5 y/o
What are risk factors of COPD?
Older age
Female
Lower socio-economic status
Asthma/airway hypersensitivity
What does damage to lung tissue in COPD cause?
An obstruction to the flow of air through the airways making it more difficult to ventilate the lungs and making them prone to developing infections.
Presentation
Chronic productive cough for at least 3 months in at least 2 consecutive years
without other identifiable cause
Purulent sputum production
Hypoxia
Hypercapnia
Exertional dyspnoea
Cyanosis (‘Blue bloaters’)
Peripheral oedema secondary to cor pulmonale
What does COPD not cause?
Clubbing
Haemoptysis
Chest pain
What can chronic hypoxia cause and how?
Right ventricular hypertrophy
Pulmonary arteriolar vasoconstriction -> increased pulmonary hypertension
What happens in severe COPD?
Hypoxic drive -> body relies on central chemoreceptors
Cor pulmonale
MRC scale to assess breathlessness
Grade 1 – Breathless on strenuous exercise
Grade 2 – Breathless on walking up hill
Grade 3 – Breathless that slows walking on the flat
Grade 4 – Stop to catch their breath after walking 100 meters on the flat
Grade 5 – Unable to leave the house due to breathlessness
When can COPD be diagnosed?
If ALL criteria met:
- Typical symptoms
- > 35 y.o
- No asthma clinical features
AND
Airflow obstruction confirmed by post-bronchodilator spirometry (no reversibility shown with bronchodilators, excluding asthma)
Spirometry - <0.7
What spirometry results are needed for diagnosis ?
Obstructive picture
FEV1/FVC ratio <0.7
FEV1 decreased
FVC normal or decreased
Decreased ratio
No dramatic result to reversibility testing with beta-2-agonists
Severity of airway obstruction using FEV1
Stage 1: FEV1 >80% of predicted
Stage 2: FEV1 50-79% of predicted
Stage 3: FEV1 30-49% of predicted
Stage 4: FEV1 <30% of predicted
Blood work results
FBC (raised PCV; polycythaemia)
ABG (reduced PaO2 +/- raised PaCO2 or type 2 respiratory failure)
ECG results
P-pulmonale (right atrial hypertrophy) and right ventricular hypertrophy, if there is cor pulmonale
CXR results
Hyperinflated chest (>6 anterior ribs)
Bullae
Decreased peripheral vascular markings
Flattened hemidiaphragms
Suspended small heart
Non-pharmacological management
Smoking cessation
Vaccination (flu yearly + pneumococcal every 5 years)
Pulmonary rehab
Nutritional assessment
Psychological support
Long term management
Step One
Short acting bronchodilators:
beta-2 agonists (salbutamol or terbutaline) or short acting antimuscarinics (ipratropium bromide).